NCT05377216EARLY_PHASE1Recruiting

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

University of Pennsylvania

Start Date

9/1/2022

Completion Date

7/1/2027

Summary

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Planned catheter based VT ablation * Age at least 18 years Exclusion Criteria: * Pregnancy * Contraindication to SGB or VT ablation * Hypersensitivity of local anesthetic of amide type * Hemodynamic instability during the procedure prior to the study protocol

Interventions

DRUG

Stellate Ganglion Block

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Ventricular Tachycardia

Locations

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania 19104

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.